Loading insider details...
Beta
Latest Form 4 (Jul 16, 2026): Exercise/Conversion of 4,351 GLUE shares, $17.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Exercise/Conversion | 4,351 | $17.3K |
| Jun 25, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Exercise/Conversion | 2,175 | $8.7K |
| Jun 18, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Exercise/Conversion | 2,176 | $8.7K |
| May 28, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Exercise/Conversion | 2,175 | $8.7K |
| May 26, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Exercise/Conversion | 2,176 | $8.7K |
| Jan 5, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 35,000 | n/a |
| Jan 6, 2025 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 30,000 | n/a |
| Jun 5, 2024 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 40,000 | n/a |